Yi Pan

2.2k total citations · 1 hit paper
41 papers, 1.7k citations indexed

About

Yi Pan is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Yi Pan has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 12 papers in Molecular Biology and 11 papers in Epidemiology. Recurrent topics in Yi Pan's work include Autophagy in Disease and Therapy (6 papers), Cardiovascular Function and Risk Factors (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Yi Pan is often cited by papers focused on Autophagy in Disease and Therapy (6 papers), Cardiovascular Function and Risk Factors (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (4 papers). Yi Pan collaborates with scholars based in Canada, China and United States. Yi Pan's co-authors include Adrian Quan, Subodh Verma, Fina Lovren, Hwee Teoh, Mohammed Al‐Omran, Praphulla Chandra Shukla, Krishna K. Singh, Milan Gupta, Mark D. Peterson and Paul E. Szmitko and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Yi Pan

38 papers receiving 1.7k citations

Hit Papers

Association of Insulin Resistance With Cardiovascular Dis... 2024 2026 2025 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Pan Canada 18 591 464 457 392 242 41 1.7k
Kazuyuki Hida Japan 20 516 0.9× 700 1.5× 336 0.7× 487 1.2× 183 0.8× 37 1.8k
Chaoyong He China 20 1.0k 1.8× 638 1.4× 337 0.7× 314 0.8× 296 1.2× 39 2.2k
Wenhui Peng China 23 593 1.0× 249 0.5× 372 0.8× 200 0.5× 197 0.8× 71 1.5k
Gila Idelman United States 15 469 0.8× 216 0.5× 419 0.9× 283 0.7× 297 1.2× 22 1.2k
Praphulla Chandra Shukla India 17 784 1.3× 262 0.6× 555 1.2× 352 0.9× 178 0.7× 39 1.8k
Kimihiko Kato Japan 26 829 1.4× 237 0.5× 376 0.8× 162 0.4× 289 1.2× 83 1.9k
Stefan K. Nilsson Sweden 21 554 0.9× 366 0.8× 580 1.3× 443 1.1× 353 1.5× 39 1.9k
Cheng‐Chao Ruan China 26 462 0.8× 228 0.5× 477 1.0× 327 0.8× 239 1.0× 67 1.6k
Ying Yu China 23 412 0.7× 211 0.5× 300 0.7× 223 0.6× 229 0.9× 50 1.5k
John Fassett United States 28 1.1k 1.8× 211 0.5× 742 1.6× 456 1.2× 297 1.2× 46 2.2k

Countries citing papers authored by Yi Pan

Since Specialization
Citations

This map shows the geographic impact of Yi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Pan more than expected).

Fields of papers citing papers by Yi Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Pan. The network helps show where Yi Pan may publish in the future.

Co-authorship network of co-authors of Yi Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Pan. A scholar is included among the top collaborators of Yi Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Pan. Yi Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Yi, et al.. (2025). Hydroxysafflor yellow A for ischemic heart diseases: a systematic review and meta-analysis of animal experiments. Frontiers in Pharmacology. 16. 1510657–1510657.
2.
Su, Tong, Long Xie, Yi Pan, et al.. (2024). Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis. Diabetology & Metabolic Syndrome. 16(1). 208–208. 4 indexed citations
3.
Sun, Rui, Jianxin Wang, Meng Li, et al.. (2024). Association of Insulin Resistance With Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes: Systematic Review and Meta-analysis. Diabetes Care. 47(12). 2266–2274. 42 indexed citations breakdown →
5.
Mistry, Nikhil, Kim A. Connelly, Andrew T. Yan, et al.. (2023). IGFBP7 and Left Ventricular Mass Regression: A Sub-Analysis of the EMPA-HEART CardioLink-6 Randomized Clinical Trial. ESC Heart Failure. 10(3). 2113–2119. 3 indexed citations
6.
Verma, Subodh, Adrian Quan, Chao‐Hung Wang, et al.. (2023). Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling. American Journal of Physiology-Heart and Circulatory Physiology. 325(5). H1210–H1222. 8 indexed citations
7.
Pan, Yi, et al.. (2023). REGENERATIVE CELL EXHAUSTION AND CARDIOVASCULAR RISK IN SOUTH ASIANS: A PILOT STUDY. Journal of the American College of Cardiology. 81(8). 1205–1205. 1 indexed citations
9.
Chowdhury, Biswajit, Yi Pan, Mohammed Al‐Omran, et al.. (2021). Loss of endothelial cell-specific autophagy-related protein 7 exacerbates doxorubicin-induced cardiotoxicity. Biochemistry and Biophysics Reports. 25. 100926–100926. 8 indexed citations
10.
Li, Fenfen, Jing Jia, Xin Cui, et al.. (2021). Epigenetic interaction between UTX and DNMT1 regulates diet-induced myogenic remodeling in brown fat. Nature Communications. 12(1). 6838–6838. 18 indexed citations
11.
Chowdhury, Biswajit, M. Golam Kabir, Yi Pan, et al.. (2020). The SGLT2 inhibitor empagliflozin reduces mortality and prevents progression in experimental pulmonary hypertension. Biochemical and Biophysical Research Communications. 524(1). 50–56. 84 indexed citations
12.
Altamimi, Tariq, Biswajit Chowdhury, Krishna K. Singh, et al.. (2018). A novel role of endothelial autophagy as a regulator of myocardial fatty acid oxidation. Journal of Thoracic and Cardiovascular Surgery. 157(1). 185–193. 8 indexed citations
13.
Wang, Lin, Yi Pan, Meiqin Huang, et al.. (2017). PAQR3 augments amino acid deprivation-induced autophagy by inhibiting mTORC1 signaling. Cellular Signalling. 33. 98–106. 9 indexed citations
14.
Zhang, Yuxue, Chunchun Liu, Daqian Xu, et al.. (2014). Luteolin Alleviates Alcoholic Liver Disease Induced by Chronic and Binge Ethanol Feeding in Mice. Journal of Nutrition. 144(7). 1009–1015. 73 indexed citations
15.
Singh, Krishna K., Fina Lovren, Yi Pan, et al.. (2014). The Essential Autophagy Gene ATG7 Modulates Organ Fibrosis via Regulation of Endothelial-to-Mesenchymal Transition. Journal of Biological Chemistry. 290(5). 2547–2559. 96 indexed citations
16.
Singh, Krishna K., Praphulla Chandra Shukla, Bobby Yanagawa, et al.. (2013). Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1. Journal of Thoracic and Cardiovascular Surgery. 146(3). 702–709. 22 indexed citations
17.
Singh, Krishna K., Bobby Yanagawa, Adrian Quan, et al.. (2013). Autophagy gene fingerprint in human ischemia and reperfusion. Journal of Thoracic and Cardiovascular Surgery. 147(3). 1065–1072.e1. 42 indexed citations
18.
Verma, Subodh, Fina Lovren, Yi Pan, et al.. (2013). Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study†. European Journal of Cardio-Thoracic Surgery. 45(4). 717–725. 72 indexed citations
19.
Singh, Krishna K., Praphulla Chandra Shukla, Adrian Quan, et al.. (2011). BRCA2 Protein Deficiency Exaggerates Doxorubicin-induced Cardiomyocyte Apoptosis and Cardiac Failure. Journal of Biological Chemistry. 287(9). 6604–6614. 44 indexed citations
20.
Lovren, Fina, Yi Pan, Praphulla Chandra Shukla, et al.. (2009). Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis. American Journal of Physiology-Endocrinology and Metabolism. 296(6). E1440–E1449. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026